Navigation Links
Nobel Laureate Dr. Oliver Smithies to Deliver Plenary Session at ISPE Biotechnology Symposium
Date:7/26/2013

Tampa, FL (PRWEB) July 26, 2013

Delegates will gain from the vast knowledge of Nobel Laureate, Dr. Oliver Smithies, during his plenary session “Where Do Ideas Come From” at ISPE’s Biotechnology, a two-day Symposium August 27-28, 2013 in Durham, NC.

Smithies is the Weatherspoon Eminent Distinguished Professor of Pathology and Laboratory Medicine at University of North Carolina. In the 1950s, he described the first high resolution electrophoresis system (starch gel), and discovered that normal humans have unsuspected inherited differences in their proteins. His technique of starch-gel electrophoresis opened vast areas of new study. With this technique, Smithies uncovered protein polymorphisms in normal persons and worked on the heredity of several blood proteins.

In 1985, Smithies described his second ground-breaking technique – the use of homologous recombination to alter a human gene in a living cell. With this technique, he has determined how genes affect blood pressure in healthy persons, and how the same genes influence the kidney problems that affect some people with diabetes.

In addition to Smithies’ presentation, Dr. James Talton, CEO Nanotherapeutics and David Doleski, Director, Division of Good Manufacturing Practice Assessment, CDER, FDA, will present. Talton is a co-inventor of Nanotherapeutics' technologies and has several authored peer-reviewed publications and book chapters involved in drug delivery systems with a primary focus in drug analysis and controlled release formulations, pharmacokinetics, and pulmonary drug delivery.

“These expert speakers will serve as outstanding leads into this new conference that explores advances in biopharmaceutical manufacturing, facility design and integration to help companies develop and validate future projects and next-generation manufacturing systems,”
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Dr. Rongxiang Xu, Patent Owner of Damaged Organ Regeneration, a Top Priority Addressed in the 2013 Presidential State of The Union, Files Lawsuit Against 2012 Nobel Laureate Dr. Yamanaka for Deception
2. Dr. Rongxiang Xu, Owner of Patented Technology to Regenerate Damaged Organs, Announces Lawsuit Against 2012 Nobel Laureate Dr. Shinya Yamanaka
3. Une plainte contre une organisation du Prix Nobel pour diffamation et concurrence deloyale est déposée pour la première fois
4. Erste Klage gegen Nobelpreis-Organisation wegen Verleumdung und unlauterem Wettbewerb eingereicht
5. First Suit Against Nobel Prize Organization Citing Defamation And Unfair Competition Practices Is Filed
6. Specialty Chemical Forum 2012 Kicks Off in Houston; AkzoNobels Frank Sherman Delivers Keynote Address
7. Telome Health Co-founder and Nobel Laureate Elizabeth Blackburn Awarded Innovator of the Year
8. Syngentas Mary-Dell Chilton named 2013 World Food Prize laureate
9. The Energy Scientific World Acclaims the Global Energy Prize 2012 Laureates
10. Laureate Biopharma Names James D. Utterback to Board of Directors
11. Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... NEW YORK , Oct. 22, 2014 ... Diabetes Federation, approximately 400 million people worldwide are living ... 552 million people by 2030.  The global market for ... In 2012 approximately 330,000 people worldwide died from pancreatic ... of death due to cancer in the ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
(Date:10/20/2014)... Calif. , Oct. 20, 2014 ... that the Company has signed a Notice of ... Regenerative Medicine (CIRM), effective October 1, 2014.  The ... Development payments and the release of additional grant ... CIRM grant award for clinical development of Asterias, ...
(Date:10/20/2014)... , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... Horovitz , Ph.D., from its board of directors effective on ... August 2003, and served as its chairman from June 2006 ... the Nominating and Corporate Governance and Audit Committees of the ... than a decade of dedicated service to GenVec, and its ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2
... NEW YORK, July 7, 2011 ... new market research report is available ... Tele-Health Monitoring: Market Shares, Strategies, and ... http://www.reportlinker.com/p0569001/Tele-Health-Monitoring-Market-Shares-Strategies-and-Forecasts-Worldwide-2011-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=e-Healthcare ...
... SAFC®, a member of the Sigma-Aldrich® Group (NASDAQ: ... first offering in a product line of Zinc Finger ... for use in the production of biopharmaceuticals, the CHOZN® ... the market faster and more cost-effectively by reducing timelines ...
... the space shuttle Atlantis will streak skyward from the Kennedy ... the STS-135 flight marks the end of the space shuttle,s ... of research into infectious diseases, thanks to space bound experiments ... with their colleagues at Arizona State University,s Biodesign Institute. ...
Cached Biology Technology:Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 2Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 3Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 4Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 5Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 6Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 7Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 8Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 9Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 10Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 11Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 12Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 13Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 14Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 15Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 16Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 17Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 18SAFC Launches CHOZN ZFN-modified CHO Cell Lines to Enhance Speed of Bioproduction 2SAFC Launches CHOZN ZFN-modified CHO Cell Lines to Enhance Speed of Bioproduction 3SAFC Launches CHOZN ZFN-modified CHO Cell Lines to Enhance Speed of Bioproduction 4Final countdown: Atlantis to carry next-generation vaccine candidate on last space voyage 2Final countdown: Atlantis to carry next-generation vaccine candidate on last space voyage 3Final countdown: Atlantis to carry next-generation vaccine candidate on last space voyage 4
(Date:10/14/2014)... shows SIRT6—a protein known to inhibit the growth ... skin cancers by turning on an enzyme that increases ... Previously considered protective, SIRT6 is part of a family ... stability and prevent some of the genetic flaws associated ... lead to cancer. This study, in the journal,s October ...
(Date:10/14/2014)... sequenced the house fly genome for the first time, ... an insect that thrives in pathogen-rich dung piles and ... the journal Genome Biology , will increase understanding ... flies quickly adapt to resist insecticides, which could lead ... domestica) carry and transmit more than 100 human and ...
(Date:10/14/2014)... kind of stem cell that can become either a liver ... to a study published today in the journal Stem ... contradicts current theory on how organs arise from cell layers ... and future treatment for, liver cancer., Thanks to stem cells, ... made up of more than 200 cell types. The original, ...
Breaking Biology News(10 mins):Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2House fly genome reveals expanded immune system 2Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 2Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 3
... infertility is a common medical problem, affecting millions of ... an inability to make productive sperm. Now, using yeast ... Pennsylvania School of Medicine are beginning to identify the ... Shelley Berger PhD, the Daniel S. Och ...
... The cave bear started to become extinct in Europe 24,000 ... international team of scientists has analysed mitochondrial DNA sequences from ... brown bear. The results show that the decline of the ... by human expansion than by climate change. "The decline ...
... Florida study indicates extinct carnivorous mammals shrank in size during a ... The study, scheduled to appear in the December print edition of ... describes a new species that evolved to half the size of ... hyena-like animal, Palaeonictis wingi , evolved from the size of ...
Cached Biology News:Swimming upstream: Molecular approaches to better understand male infertility 2Swimming upstream: Molecular approaches to better understand male infertility 3True causes for extinction of cave bear revealed 2UF study shows carnivore species shrank during global warming event 2
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
... to Protein A and, until recently, no readily ... IgM purification. Standard methods for IgM purification generally ... effective for removing all of the major impurities ... Pierce has developed an easy-to-use affinity matrix ...
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
Mouse monoclonal antibody to PARK2 - Parkinson disease (autosomal recessive, juvenile) 2, parkin...
Biology Products: